|
新聞出版品
|
癌症藥物新聞 是由出版商Espicom Business Intelligence在Issues / Year: 44所出版的。
這份英文新聞出版品價格從美金1080起跳。
抗癌藥物市場在風平浪靜的外表下有著最嚴峻的外在環境，而抗癌市場利益 之大為眾所公認。
Espicom在眾多發展抗癌市場的廠商、 商品、疾病 與研究中任重道遠， 已開創抗癌的新刊物。
Cancer Drug News (CDN)為您節省時間與精力，為您確認與全球市場接軌的必備資訊。與主 要題材來源合作，匯集Espicom獨一無二的檔案資料，CNS Drug News 提供具說服力，簡明易懂的途徑來 為您開闢市場機制。
每期單行本內容包含：
- 癌症相關併發症之治療
- 併發症
- 一般發展新聞
- 會議目錄
以下標題將在每月論述(依版面而定)：
- 乳癌
- 血癌
- 肝癌
- 腸胃癌
- 肺癌
- 婦科癌症
- 泌尿系統癌症
- 腦瘤
- 頭部/頸部癌症
- 黑瘤/肉瘤
|
Monitoring business developments in world anticancer drug markets is becoming more and more vital as cancer, in all its guises, remains one of the most resistant conditions, and its position in the pharmaceutical industry is assured.
In an effort to stay in touch with the companies, products, alliances and research that are shaping the global cancer market, Espicom has launched this major new publication.
Cancer Drug News (CDN) can save you the time and effort of ensuring you have the necessary information to keep up-to-date with the developments in this world market. Incorporating primary resource material augmented with data from Espicom's unique intelligence base, CDN provides a compelling, easy-to-read route to complete market knowledge.
|
The following sections appear in every issue:
- Therapies for Cancer-Related Complications
- General Development News
- Conference Listings
A selection of the following topics will appear each month, depending on news availability:
- Breast Cancer
- Haematological Cancers
- Liver Cancer
- Gastro-Intestinal Cancers
- Lung Cancer
- Gynaecological Cancers
- Genito-Urinary Cancers
- Brain Tumours
- Head and Neck Cancers
- Melanoma/Sarcoma
|
